Bank of Maharashtra stock
MAHABANK.NSNSEFinancial ServicesISIN INE457A01014
77Score 77 out of 100, Strong
Price and trend
77 / 100
Price history
+59% in one yearThe chart shows daily closes over 20 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Above the 200-day line: the price is 18% above it.
Since June 2025 the 50-day line has been above the 200-day line; the trend has turned up.
Overheated: the price has risen very quickly lately (RSI 83).
The price is 2.2% below its 52-week high. Largest decline in 20 years: 91% (January 2008 to March 2020).
Chart figures for advanced users
- SMA 50$0.88
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$0.83
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)83
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDabove the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$0.60
- The lowest closing price of the last twelve months.
- Resistance$1.00
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- Bank of Maharashtra belongs to the Banks (Regional) industry (India) and, with a market value of $7.5B, is number 137 of 420 companies in its industry on MEQIRI.
- In fiscal 2026 it earned $745.81M (up 26.6% year on year).
- MEQIRI Score 77 out of 100 (Strong): rank 158 of 975 in Financial Services, median 68.
Show more
- The P/E is 8.8 (Banks (Regional) median 12.9, own median of recent years 9.7).
- Our model puts fair value at $1.28, with the price 24% below it.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- Earnings per share growingUp 58.6% a year since 2021.Growth 100
- High return on equityReturn on equity 22.9% over the last 12 months.Profitability 73
- Below fair valuePrice 24% below the fair value of $1.28.Valuation 88
Weaknesses
- DilutionShare count up 23% since 2021.Capital allocation 52
Its standout strengths are growth and valuation.
Daily figure as of 13 Nov 2026
How the score is calculatedScore overview
Score since yesterday from 78 to 77.
The fundamentals are strong overall.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansCrash risk not measured
How well MEQIRI warnsFor stocks from Japan, China, Hong Kong, Taiwan, Korea, Canada, India and Brazil we only show crash risk once a separate backtest shows that it warns as well there as in the US and Europe.
Valuation
Valuation signal
Significantly undervaluedIn our model the price counts as cheap below $0.98 and expensive above $1.82 (uncertainty medium, based on the price swings of the past year).
The two parts of the fair value come to $1.13 (excess return model) and $1.42 (industry comparison), and the gap between them shows how uncertain the estimate is. The price is below both.
Calculated with a cost of equity of 12.6%. At 13.6% the fair value would be $1.19, at 11.6% it would be $1.40.
Valuation metrics
Half from the excess return model, half from earnings times the industry P/E (12.9).
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In the twelve months to 30 Sep 2026, revenue rose 32.1% on the twelve months before. Revenue has grown strongly since 2007, at around 15% per year.
Margins
- Operating margin
- Net margin
In fiscal 2026: operating 46%, net 41%. Banks and insurers have no gross margin, and their net margin is not comparable with other industries. The score leaves both out.
Debt & balance sheet
latest quarterFor banks and insurers, deposits and liabilities are the business. Debt to equity and the current ratio say little here, and the score does not rate them.
Earnings
- Next earnings
- 14 Feb 2027in 93 days
- Last reported
- 26 Oct 2026EPS reported $0.03
Analyst estimates
- Earnings per share
- $0.12+10.5%
- Revenue
- $2.2B+1.8%
- Earnings per share
- $0.13+5.4%
- Revenue
- $2.61B+2.7%
MEQIRI has stored the estimates since 24 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
Company outlook confirmed
Share price after the results: +6.2%Bank of Maharashtra confirms its full-year guidance, with domestic credit growth above 18% and capital ratios staying above its own targets.
“Going forward, yes, this window is not there, but coming on the domestic side, I have the guidance number of 18%, and other than IBU, we have grown 23%.”The outlook is not part of the score and not a recommendation to buy or sell.
From the earnings call on 26 Oct 2026 (fiscal Q2 2027), read by AI.
What happened at Bank of Maharashtra
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
975 rated companies in Financial Services
- This company
- 77
- Sector median
- 68
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Banks (Regional)
The next larger and next smaller companies by market value
- Shanghai Commercial & Savings Bank5876.TW $7.84B60
- AU Small Finance BankAUBANK.NS $7.8B69
- Credito EmilianoCE.MI $7.73B77
- IndusInd BankINDUSINDBK.NS $7.71B47
- Banca GeneraliBGN.MI $7.42B77
- IDFC First BankIDFCFIRSTB.NS $7.42B60
- Bank MillenniumMIL.WA $7.37B74
- Kyoto Financial Group,Inc.5844.T $7.35B67
ETFs that hold Bank of Maharashtra
Held by 9 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| Vanguard FTSE Emerging Markets UCITS ETF (USD) AccumulatingVFEA | 0.01% | 0.17% | €5.24B |
| Vanguard FTSE All-World High Dividend Yield UCITS ETF (USD) AccumulatingVGWE | 0.00% | 0.29% | €13.67B |
| Vanguard ESG Global All Cap UCITS ETF (USD) AccumulatingV3AA | 0.00% | 0.24% | €1.69B |
Show 3 more
| Vanguard FTSE All-World UCITS ETF (USD) AccumulatingVWCE | 0.00% | 0.14% | €79.59B |
| Amundi Prime All Country World UCITS ETF AccWEBN | 0.00% | 0.07% | €8.95B |
| Vanguard FTSE Global All-Cap UCITS ETF Accum USDVGLA | 0.00% | 0.07% | €3.9B |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2026, period end 31 Mar 2026
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = ₹94.0836)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Strong, published since 7 Nov 2026 (in the score history since 12 Sep 2025)
- Valuation signal Undervalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.